Process for producing crystals of polymorphic 2-(3-cyano-4-isobutyloxyphenyl) - 4-methyl-5-thiazole-caboxylic acid by poor-solvent addition method

Details for Australian Patent Application No. 2010271717 (hide)

Owner Teijin Pharma Limited

Inventors Uemura, Akihito; Nogata, Tomoaki; Takeyasu, Takumi

Agent Davies Collison Cave

Pub. Number AU-A-2010271717

PCT Pub. Number WO2011/007895

Priority 2009-166755 15.07.09 JP

Filing date 14 July 2010

Wipo publication date 20 January 2011

International Classifications

C07D 277/20 (2006.01) Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings

A61K 31/426 (2006.01) - 1,3-Thiazoles

A61P 19/06 (2006.01) Drugs for skeletal disorders

C07D 277/56 (2006.01) Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings

Event Publications

19 January 2012 PCT application entered the National Phase

  PCT publication WO2011/007895 Priority application(s): WO2011/007895

8 March 2012 Corrigenda

  PCT applications that have entered the National Phase - Name Index Under the name Teijin Pharma Limited, Application No. 2010271717, under INID (54) correct the title to Process for producing crystals of polymorphic 2-(3-cyano-4-isobutyloxyphenyl) -4-methyl-5-thiazolecaboxylic acid by poor-solvent addition method

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2010271722-Pluripotent stem cell that can be isolated from body tissue

2010271713-Nose pipe instrument capable of modulating the tone thereof